Literature DB >> 33474582

Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.

Marilena Savoia1, Francesca Rech Morassutti2, Luigi Castriotta3, Daisy Pavoni4, Peter M Mourani5, Paola Freschi2, Luigi Cattarossi2, Antonio Tonutti2.   

Abstract

Neonatologist-performed echocardiography (NPE) is an established tool for bedside hemodynamic evaluation, including pulmonary hypertension (PH). PH may complicate bronchopulmonary dysplasia (BPD) course. Aims of this retrospective study were to assess the feasibility of NPE follow-up of infants with BPD and to describe the course of PH of infants with moderate/severe BPD. Preterm infants <32 gestational weeks or birthweight ≤1500 g with moderate/severe BPD underwent NPE follow-up, from 36 weeks postmenstrual age up to 8 months postnatal age. Twenty-three preemies were included (birth weight 840 (213) g, gestational age 26.8 (2.3) weeks); 12/23 developed mild PH, 2/12 after discharge. PH resolved at 8.9 (3.9) months. Clinical and echocardiographic variables did not differ between infants with and without PH, except pulmonary artery acceleration time (PAAT) and PAAT/right ventricle ejection time (RVET) ratio (PAAT: 36 weeks, 68.9 (11.9) vs 52.0 (19.1), p = 0.0443; 6 months: 83.9 (38.9) vs 74.8 (16.9), p = 0.0372). No deaths or admissions for PH were reported. Neonatologist's Image Quality Assessment score attributed by the cardiologist assumed as gold standard was adequate or optimal (9.5/14 total score); inter-rater agreement was excellent (ICC 0.974).Conclusions: NPE follow-up seems to be feasible and safe in both intensive care and outpatient clinic. Mild PH is frequently detected in moderate/severe BPD, with good prognosis. What is Known: • Preterm infants with bronchopulmonary dysplasia (BPD) may develop pulmonary hypertension (PH) and have a late diagnosis. • Neonatologist-performed echocardiography (NPE) is an established tool for bedside hemodynamic evaluation of the neonate. What is New: • To our knowledge this is the first study of NPE follow-up of moderate/severe BPD, describing the course of mild PH from diagnosis to its resolution. • NPE follow-up of BPD seems to be safe and practicable, in both intensive care and outpatient clinic, as long as neonatologists maintain a sound collaboration with pediatric cardiologists.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Functional echocardiography; Neonatologist-performed echocardiography; Premature infant; Pulmonary hypertension

Year:  2021        PMID: 33474582     DOI: 10.1007/s00431-021-03954-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

1.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

2.  Statement on the care of the child with chronic lung disease of infancy and childhood.

Authors:  Julian Allen; Robert Zwerdling; Richard Ehrenkranz; Claude Gaultier; Robert Geggel; Anne Greenough; Ronald Kleinman; Anne Klijanowicz; Fernando Martinez; Ali Ozdemir; Howard B Panitch; Bruce Nickerson; Martin T Stein; Jean Tomezsko; John Van Der Anker
Journal:  Am J Respir Crit Care Med       Date:  2003-08-01       Impact factor: 21.405

3.  Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes.

Authors:  Maria Jesús del Cerro; Anna Sabaté Rotés; Antonio Cartón; Lucia Deiros; Montserrat Bret; Malaika Cordeiro; Cristina Verdú; Maria Isabel Barrios; Luis Albajara; Federico Gutierrez-Larraya
Journal:  Pediatr Pulmonol       Date:  2013-06-20

4.  BTS guidelines for home oxygen in children.

Authors:  I M Balfour-Lynn; D J Field; P Gringras; B Hicks; E Jardine; R C Jones; A G Magee; R A Primhak; M P Samuels; N J Shaw; S Stevens; C Sullivan; J A Taylor; C Wallis
Journal:  Thorax       Date:  2009-08       Impact factor: 9.139

5.  Targeted Neonatal Echocardiography in the Neonatal Intensive Care Unit: practice guidelines and recommendations for training. Writing Group of the American Society of Echocardiography (ASE) in collaboration with the European Association of Echocardiography (EAE) and the Association for European Pediatric Cardiologists (AEPC).

Authors:  Luc Mertens; Istvan Seri; Jan Marek; Romaine Arlettaz; Piers Barker; Patrick McNamara; Anita J Moon-Grady; Patrick D Coon; Shahab Noori; John Simpson; Wyman W Lai
Journal:  J Am Soc Echocardiogr       Date:  2011-10       Impact factor: 5.251

6.  Neonatal anthropometric charts: the Italian neonatal study compared with other European studies.

Authors:  Enrico Bertino; Elena Spada; Luciana Occhi; Alessandra Coscia; Francesca Giuliani; Luigi Gagliardi; Giulio Gilli; Gianni Bona; Claudio Fabris; Mario De Curtis; Silvano Milani
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-09       Impact factor: 2.839

7.  Oxygen Targeting in Extremely Low Birth Weight Infants.

Authors:  James J Cummings; Richard A Polin
Journal:  Pediatrics       Date:  2016-08       Impact factor: 7.124

8.  Lung ultrasound in respiratory distress syndrome: a useful tool for early diagnosis.

Authors:  Roberto Copetti; Luigi Cattarossi; Franco Macagno; Marco Violino; Riccardo Furlan
Journal:  Neonatology       Date:  2008-01-15       Impact factor: 4.035

Review 9.  Introduction to neonatologist-performed echocardiography.

Authors:  Alan M Groves; Yogen Singh; Eugene Dempsey; Zoltan Molnar; Topun Austin; Afif El-Khuffash; Willem P de Boode
Journal:  Pediatr Res       Date:  2018-07       Impact factor: 3.756

Review 10.  Tissue Doppler velocity imaging and event timings in neonates: a guide to image acquisition, measurement, interpretation, and reference values.

Authors:  Eirik Nestaas; Ulf Schubert; Willem P de Boode; Afif El-Khuffash
Journal:  Pediatr Res       Date:  2018-07       Impact factor: 3.756

View more
  1 in total

1.  [Expert consensus on the follow-up management of bronchopulmonary dysplasia in preterm infants after discharge].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.